It is appropriate to maintain in Regulation (EC) No 726/2004 certain provisions relating to veterinary medicinal products, in particular those relating to the European Medicines Agency (‘the Agency’), but as the procedures applicable to the centralised marketing authorisation of veterinary medicinal products are laid down in Regulation (EU) 2019/6, the parts of Regulation (EC) No 726/2004 that relate to procedures for such marketing authorisations and that are covered by Regulation (EU) 2019/6 should be repealed.
Is iomchuí go ndéanfar forálacha áirithe a bhaineann le táirgí íocshláinte tréidliachta, go háirithe iad sin a bhaineann leis an nGníomhaireacht Leigheasra Eorpach (“an Ghníomhaireacht”), a choinneáil i Rialachán (CE) Uimh. 726/2004, ach ós rud é go bhfuil na nósanna imeachta is infheidhme maidir le húdaruithe margaíochta láraithe i leith táirgí íocshláinte tréidliachta leagtha síos i Rialachán (AE) 2019/6, ba cheart na codanna sin de Rialachán (CE) Uimh. 726/2004 a bhaineann le nósanna imeachta maidir leis na húdaruithe margaíochta sin agus a chuimsítear le Rialachán (AE) 2019/6 a aisghairm.